Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception. ACYLINE is a Protein drug with a maximum clinical trial phase of II and has 1 investigational indication. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include MER-104 and S3439D3B35. Its PubChem CID is 16137348.
Acyline
| CAS No | 170157-13-8 |
|---|---|
| Molecular Formula | C80H102ClN15O14 |
| Molecular Weight | 1533.2 g/mol |
| Synonyms | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-acetamidophenyl)propanoyl]amino]-3-(4-acetamidophenyl)propanoyl]amino]-4-methylpentanoyl]amino]-6-(propan-2-ylamino)hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception. ACYLINE is a Protein drug with a maximum clinical trial phase of II and has 1 investigational indication.
The listed CAS number is 170157-13-8.
The listed molecular formula is C80H102ClN15O14.
The listed molecular weight is 1533.2 g/mol.
The source lists MER-104 and S3439D3B35.
It is listed as a discontinued API with a synthetic origin.